| 1 |
Ren J, Xiao X, Li R, Lv C, Zhang Y, Wang L, Hong T, Zhang H, Wang Y. Single-cell sequencing reveals that endothelial cells, EndMT cells and mural cells contribute to the pathogenesis of cavernous malformations. Exp Mol Med 2023. [PMID: 36914857 DOI: 10.1038/s12276-023-00962-w] [Reference Citation Analysis]
|
| 2 |
Yang X, Wu ST, Gao R, Wang R, Wang Y, Dong Z, Wang L, Qi C, Wang X, Schmitz ML, Liu R, Han Z, Wang L, Zheng X. Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation. JCI Insight 2023;8:e160372. [PMID: 36692953 DOI: 10.1172/jci.insight.160372] [Reference Citation Analysis]
|
| 3 |
Srinath A, Xie B, Li Y, Sone JY, Romanos S, Chen C, Sharma A, Polster S, Dorrestein PC, Weldon KC, DeBiasse D, Moore T, Lightle R, Koskimäki J, Zhang D, Stadnik A, Piedad K, Hagan M, Shkoukani A, Carrión-Penagos J, Bi D, Shen L, Shenkar R, Ji Y, Sidebottom A, Pamer E, Gilbert JA, Kahn ML, D'Souza M, Sulakhe D, Awad IA, Girard R. Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma. Commun Med (Lond) 2023;3:35. [PMID: 36869161 DOI: 10.1038/s43856-023-00265-1] [Reference Citation Analysis]
|
| 4 |
Hongo H, Miyawaki S, Teranishi Y, Ishigami D, Ohara K, Sakai Y, Shimada D, Umekawa M, Koizumi S, Ono H, Nakatomi H, Saito N. Genetics of brain arteriovenous malformations and cerebral cavernous malformations. J Hum Genet 2023;68:157-67. [PMID: 35831630 DOI: 10.1038/s10038-022-01063-8] [Reference Citation Analysis]
|
| 5 |
Kuroedov D, Cunha B, Pamplona J, Castillo M, Ramalho J. Cerebral cavernous malformations: Typical and atypical imaging characteristics. J Neuroimaging 2023;33:202-17. [PMID: 36456168 DOI: 10.1111/jon.13072] [Reference Citation Analysis]
|
| 6 |
Kim S, Moon J, Jung KH, Anh SJ, Lee HS, Jang Y, Park KI, Lee SK, Chu K. Clinicoradiologic data of familial cerebral cavernous malformation with age-related disease burden. Ann Clin Transl Neurol 2023;10:373-83. [PMID: 36629374 DOI: 10.1002/acn3.51728] [Reference Citation Analysis]
|
| 7 |
Pilz RA, Skowronek D, Mellinger L, Bekeschus S, Felbor U, Rath M. Endothelial Differentiation of CCM1 Knockout iPSCs Triggers the Establishment of a Specific Gene Expression Signature. Int J Mol Sci 2023;24. [PMID: 36835400 DOI: 10.3390/ijms24043993] [Reference Citation Analysis]
|
| 8 |
Weinsheimer S, Nelson J, Abla AA, Ko NU, Tsang C, Okoye O, Zabramski JM, Akers A, Zafar A, Mabray MC, Hart BL, Morrison L, McCulloch CE, Kim H; Brain Vascular Malformation Consortium Cerebral Cavernous Malformation Investigator Group *. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation. J Am Heart Assoc 2023;12:e027572. [PMID: 36695309 DOI: 10.1161/JAHA.122.027572] [Reference Citation Analysis]
|
| 9 |
Huo R, Yang Y, Sun Y, Zhou Q, Zhao S, Mo Z, Xu H, Wang J, Weng J, Jiao Y, Zhang J, He Q, Wang S, Zhao J, Wang J, Cao Y. Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation. Angiogenesis 2023. [PMID: 36719480 DOI: 10.1007/s10456-023-09866-9] [Reference Citation Analysis]
|
| 10 |
Shenkar R, Awad IA. Credulity of exploratory trials for cerebral cavernous malformations. Lancet Neurol 2023;22:2-3. [PMID: 36403581 DOI: 10.1016/S1474-4422(22)00440-9] [Reference Citation Analysis]
|
| 11 |
Zhan Z, He D, Jiang H, Yang Z, Gao P, Zhang S, Chen Y, Huang H. Epidemiology and Survival Analysis of Patients with Brainstem Cavernous Hemangioma: A Population-Based Study Using the SEER Database.. [DOI: 10.21203/rs.3.rs-1679766/v2] [Reference Citation Analysis]
|
| 12 |
Gorick CM, Breza VR, Nowak KM, Cheng VWT, Fisher DG, Debski AC, Hoch MR, Demir ZEF, Tran NM, Schwartz MR, Sheybani ND, Price RJ. Applications of focused ultrasound-mediated blood-brain barrier opening. Adv Drug Deliv Rev 2022;191:114583. [PMID: 36272635 DOI: 10.1016/j.addr.2022.114583] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Yang X, Dai Z, Gao C, Yin Y, Shi C, Liu R, Zhuge Q, Huang Y, Zhou B, Han Z, Zheng X. Cerebral cavernous malformation development in chronic mouse models driven by dual recombinases induced gene deletion in brain endothelial cells. J Cereb Blood Flow Metab 2022;42:2230-44. [PMID: 35686705 DOI: 10.1177/0271678X221105995] [Reference Citation Analysis]
|
| 14 |
Fisher DG, Sharifi KA, Ulutas EZ, Kumar JS, Kalani MYS, Miller GW, Price RJ, Tvrdik P. Understanding Lesion Progression in a Chronic Model of Cerebral Cavernous Malformations through Combined MRI and Histology.. [DOI: 10.1101/2022.11.15.516639] [Reference Citation Analysis]
|
| 15 |
Lai CC, Nelsen B, Frias-Anaya E, Gallego-Gutierrez H, Orecchioni M, Herrera V, Ortiz E, Sun H, Mesarwi OA, Ley K, Gongol B, Lopez-Ramirez MA. Neuroinflammation Plays a Critical Role in Cerebral Cavernous Malformation Disease. Circ Res 2022;131:909-25. [PMID: 36285625 DOI: 10.1161/CIRCRESAHA.122.321129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Zou X, Wang L, Xiao L, Wang S, Zhang L. Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.975921] [Reference Citation Analysis]
|
| 17 |
Globisch MA, Onyeogaziri FC, Smith RO, Arce M, Magnusson PU. Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations. IJMS 2022;23:12575. [DOI: 10.3390/ijms232012575] [Reference Citation Analysis]
|
| 18 |
Ding J, Lee S, Vlahos L, Yuki K, Rada CC, van Unen V, Vuppalapaty M, Chen H, Sura A, Mccormick AK, Tomaske M, Alwahabi S, Nguyen H, Nowatzke W, Kim L, Kelly L, Vollrath D, Califano AJ, Yeh W, Li Y, Kuo CJ. Therapeutic modulation of the blood-brain barrier and ischemic stroke by a bioengineered FZD4-selective WNT surrogate.. [DOI: 10.1101/2022.10.13.510564] [Reference Citation Analysis]
|
| 19 |
Soon K, Li M, Wu R, Zhou A, Khosraviani N, Turner WD, Wythe JD, Fish JE, Nunes SS. A human model of arteriovenous malformation (AVM)-on-a-chip reproduces key disease hallmarks and enables drug testing in perfused human vessel networks. Biomaterials 2022;288:121729. [PMID: 35999080 DOI: 10.1016/j.biomaterials.2022.121729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Dammann P, Santos AN, Wan X, Zhu Y, Sure U. Cavernous Malformations. Neurosurgery Clinics of North America 2022. [DOI: 10.1016/j.nec.2022.05.001] [Reference Citation Analysis]
|
| 21 |
Huo R, Wang J, Sun Y, Weng J, Li H, Jiao Y, Xu H, Zhang J, Zhao S, He Q, Wang S, Zhao J, Cao Y. Simplex cerebral cavernous malformations with MAP3K3 mutation have distinct clinical characteristics. Front Neurol 2022;13:946324. [DOI: 10.3389/fneur.2022.946324] [Reference Citation Analysis]
|
| 22 |
Castillo-Rangel C, Marín G, Hernandez-Contreras KA, Zarate-Calderon C, Vichi-Ramirez MM, Cortez-Saldias W, Rodriguez-Florido MA, Riley-Moguel ÁE, Pichardo O, Torres-Pineda O, Vega-Quesada HG, Lopez-Elizalde R, Ordoñez-Granja J, Alvarado-Martinez HH, Vega-Quesada LA, Aranda-Abreu GE. Atlas of Nervous System Vascular Malformations: A Systematic Review. Life (Basel) 2022;12:1199. [PMID: 36013378 DOI: 10.3390/life12081199] [Reference Citation Analysis]
|
| 23 |
Tu T, Peng Z, Ren J, Zhang H. Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives. Front Immunol 2022;13:922281. [DOI: 10.3389/fimmu.2022.922281] [Reference Citation Analysis]
|
| 24 |
Romanos SG, Srinath A, Li Y, Xie B, Chen C, Li Y, Moore T, Bi D, Sone JY, Lightle R, Hobson N, Zhang D, Koskimäki J, Shen L, McCurdy S, Lai CC, Stadnik A, Piedad K, Carrión-Penagos J, Shkoukani A, Snellings D, Shenkar R, Sulakhe D, Ji Y, Lopez-Ramirez MA, Kahn ML, Marchuk DA, Ginsberg MH, Girard R, Awad IA. Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease. Transl Stroke Res 2022. [PMID: 35715588 DOI: 10.1007/s12975-022-01050-3] [Reference Citation Analysis]
|
| 25 |
Sun R, Liu Q, Mu L, Wang A, Zhao J, Liu L, Long Y. A familiar cerebral cavernous malformations (FCCMs) patient with CCM1 deletion-frameshift mutation generates an induced pluripotent stem cell line (NFHHMUi001-A). Stem Cell Res 2022;63:102838. [PMID: 35716468 DOI: 10.1016/j.scr.2022.102838] [Reference Citation Analysis]
|
| 26 |
Hagan MJ, Shenkar R, Srinath A, Romanos SG, Stadnik A, Kahn ML, Marchuk DA, Girard R, Awad IA. Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans. ACS Pharmacol Transl Sci 2022;5:266-77. [PMID: 35592432 DOI: 10.1021/acsptsci.2c00006] [Reference Citation Analysis]
|
| 27 |
Lai CC, Nelsen B, Frias-anaya E, Gallego-gutierrez H, Orecchioni M, Sun H, Mesarwi OA, Ley K, Gongol B, Lopez-ramirez MA. Neuroinflammation plays a critical role in cerebral cavernous malformation disease.. [DOI: 10.1101/2022.05.09.491214] [Reference Citation Analysis]
|
| 28 |
Magid-Bernstein J, Girard R, Polster S, Srinath A, Romanos S, Awad IA, Sansing LH. Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. Circ Res 2022;130:1204-29. [PMID: 35420918 DOI: 10.1161/CIRCRESAHA.121.319949] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 29 |
Hsieh PF, Liu SY, Chen CH, Chen PL, Tang SC, Jeng JS. Genetic analysis of a family presenting with coexisting cerebral cavernous malformations and polycystic kidney disease. J Formos Med Assoc 2022:S0929-6646(22)00112-7. [PMID: 35370030 DOI: 10.1016/j.jfma.2022.03.010] [Reference Citation Analysis]
|
| 30 |
Castro C, Oyamada HAA, Cafasso MOSD, Lopes LM, Monteiro C, Sacramento PM, Alves-Leon SV, da Fontoura Galvão G, Hygino J, de Souza JPBM, Bento CAM. Elevated proportion of TLR2- and TLR4-expressing Th17-like cells and activated memory B cells was associated with clinical activity of cerebral cavernous malformations. J Neuroinflammation 2022;19:28. [PMID: 35109870 DOI: 10.1186/s12974-022-02385-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Sun Z, Kemp SS, Lin PK, Aguera KN, Davis GE. Endothelial k-RasV12 Expression Induces Capillary Deficiency Attributable to Marked Tube Network Expansion Coupled to Reduced Pericytes and Basement Membranes. Arterioscler Thromb Vasc Biol 2022;42:205-22. [PMID: 34879709 DOI: 10.1161/ATVBAHA.121.316798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 32 |
Soon K, Li M, Wu R, Turner WD, Wythe JD, Fish JE, Nunes SS. Development and characterization of a human model of arteriovenous malformation (AVM)-on-a-chip.. [DOI: 10.1101/2022.01.20.477166] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 33 |
Hasan D. Editorial for "Perfusion and Permeability Magnetic Resonance Imaging (MRI) Predicts Future Cavernous Angioma Hemorrhage and Growth". J Magn Reson Imaging 2021. [PMID: 34585810 DOI: 10.1002/jmri.27944] [Reference Citation Analysis]
|
| 34 |
Blei F. Update August 2021. Lymphatic Research and Biology 2021;19:391-405. [DOI: 10.1089/lrb.2021.29108.fb] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 35 |
Tihamér M, István M, Krisztina K, Attila SJ, Szabolcs S. Cerebral microbleeds in a young patient – case presentation with rare disease association and literature review. Bulletin of Medical Sciences 2021;94:51-60. [DOI: 10.2478/orvtudert-2021-0007] [Reference Citation Analysis]
|
| 36 |
Janardhan HP, Saheera S, Jung R, Trivedi CM. Vascular and Lymphatic Malformations: Perspectives From Human and Vertebrate Studies. Circ Res 2021;129:131-5. [PMID: 34166069 DOI: 10.1161/CIRCRESAHA.121.319587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
